NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 914 filers reported holding NOVARTIS A G in Q4 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,670,297 | +2.4% | 1,057,042 | +1.4% | 0.22% | +6.3% |
| Q2 2023 | $105,179,703 | -13.8% | 1,042,312 | -21.4% | 0.20% | -20.8% |
| Q1 2023 | $122,006,352 | +65.2% | 1,326,156 | +62.9% | 0.26% | +56.0% |
| Q4 2022 | $73,872,117 | +11.4% | 814,287 | -6.7% | 0.17% | +14.5% |
| Q3 2022 | $66,337,000 | -14.5% | 872,741 | -4.9% | 0.14% | -9.4% |
| Q2 2022 | $77,573,000 | +30.3% | 917,699 | +35.2% | 0.16% | +41.6% |
| Q1 2022 | $59,551,000 | +337.1% | 678,661 | +335.7% | 0.11% | +352.0% |
| Q4 2021 | $13,625,000 | +627.4% | 155,773 | +572.4% | 0.02% | -67.9% |
| Q1 2018 | $1,873,000 | -6.1% | 23,166 | -2.5% | 0.08% | -7.1% |
| Q4 2017 | $1,994,000 | +68.6% | 23,750 | +72.6% | 0.08% | +52.7% |
| Q3 2017 | $1,183,000 | -6.0% | 13,758 | -9.3% | 0.06% | 0.0% |
| Q2 2017 | $1,259,000 | -96.5% | 15,169 | -96.9% | 0.06% | -76.8% |
| Q4 2016 | $36,022,000 | +1.6% | 494,535 | +10.1% | 0.24% | -6.0% |
| Q3 2016 | $35,460,000 | -5.5% | 449,083 | -1.2% | 0.25% | -20.0% |
| Q2 2016 | $37,505,000 | +87.6% | 454,553 | +110.7% | 0.32% | +19.3% |
| Q4 2014 | $19,988,000 | – | 215,718 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |